CARECLOUD INC (CCLD) Stock Fundamental Analysis
USA - NASDAQ:CCLD - US14167R1005 - Common Stock
3.5 USD
-0.1 (-2.78%)
Overall CCLD gets a fundamental rating of 5 out of 10. We evaluated CCLD against 35 industry peers in the Health Care Technology industry. CCLD has only an average score on both its financial health and profitability. CCLD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CCLD had negative earnings in the past year.
CCLD had a positive operating cash flow in the past year.
CCLD had negative earnings in each of the past 5 years.
CCLD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCLD has a Return On Assets of 0.02%. This is amongst the best in the industry. CCLD outperforms 82.86% of its industry peers.
Looking at the Return On Equity, with a value of 0.02%, CCLD belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.12%, CCLD belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROIC | 16.12% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 0.01%, CCLD belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
Looking at the Operating Margin, with a value of 10.77%, CCLD belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
CCLD's Operating Margin has improved in the last couple of years.
The Gross Margin of CCLD (46.00%) is worse than 68.57% of its industry peers.
In the last couple of years the Gross Margin of CCLD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCLD is creating some value.
CCLD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CCLD has been increased compared to 5 years ago.
Compared to 1 year ago, CCLD has an improved debt to assets ratio.
2.2 Solvency
CCLD has an Altman-Z score of 5.87. This indicates that CCLD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CCLD (5.87) is better than 80.00% of its industry peers.
CCLD has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
CCLD's Debt to FCF ratio of 0.02 is amongst the best of the industry. CCLD outperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CCLD is not too dependend on debt financing.
CCLD has a Debt to Equity ratio of 0.00. This is in the better half of the industry: CCLD outperforms 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 5.87 |
ROIC/WACC1.64
WACC9.85%
2.3 Liquidity
A Current Ratio of 1.91 indicates that CCLD should not have too much problems paying its short term obligations.
CCLD has a Current ratio (1.91) which is comparable to the rest of the industry.
CCLD has a Quick Ratio of 1.88. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
CCLD has a Quick ratio (1.88) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
CCLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.70%, which is quite impressive.
The Revenue has been growing slightly by 0.04% in the past year.
The Revenue has been growing by 11.47% on average over the past years. This is quite good.
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
3.2 Future
CCLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.79% yearly.
Based on estimates for the next years, CCLD will show a quite strong growth in Revenue. The Revenue will grow by 11.66% on average per year.
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.08%
Revenue Next 2Y11.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCLD. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 22.38, the valuation of CCLD can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCLD indicates a rather cheap valuation: CCLD is cheaper than 82.86% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CCLD to the average of the S&P500 Index (23.21), we can say CCLD is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.38 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than CCLD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCLD is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.51 | ||
| EV/EBITDA | 5.98 |
4.3 Compensation for Growth
CCLD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCLD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CCLD's earnings are expected to grow with 66.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CCLD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CCLD (10/8/2025, 3:27:07 PM)
3.5
-0.1 (-2.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners19.86%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner Change1.12%
Market Cap148.12M
Analysts80
Price Target4.85 (38.57%)
Short Float %1.76%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.82%
Min EPS beat(2)21.57%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)72.28%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)-0.12%
EPS beat(12)8
Avg EPS beat(12)-1.47%
EPS beat(16)12
Avg EPS beat(16)11.57%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)1
Avg Revenue beat(12)-3.19%
Revenue beat(16)3
Avg Revenue beat(16)-2.21%
PT rev (1m)31.03%
PT rev (3m)7.55%
EPS NQ rev (1m)-18.19%
EPS NQ rev (3m)-35.72%
EPS NY rev (1m)-22.58%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)4.63%
Revenue NY rev (3m)4.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.38 | ||
| P/S | 1.32 | ||
| P/FCF | 8.51 | ||
| P/OCF | 5.97 | ||
| P/B | 2.64 | ||
| P/tB | 6.93 | ||
| EV/EBITDA | 5.98 |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.16
Fwd EY4.47%
FCF(TTM)0.41
FCFY11.76%
OCF(TTM)0.59
OCFY16.75%
SpS2.64
BVpS1.33
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROCE | 20.4% | ||
| ROIC | 16.12% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 39.14% | ||
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% | ||
| FCFM | 15.58% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 54.79% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | 63.03 | ||
| Cash Conversion | 97.14% | ||
| Profit Quality | 124386% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 5.87 |
F-Score7
WACC9.85%
ROIC/WACC1.64
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
Revenue Next Year5.08%
Revenue Next 2Y11.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15735.1%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year209.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y21.45%
OCF growth 3Y15.69%
OCF growth 5Y22.06%